To further explore the selectivity of the effects of PAFAH1B1 suppression in tumor versus non-transformed cells, beyond the single cell line evaluated in the CRISPR screen (Fig. 1B), we transiently silenced PAFAH1B1 in two additional non-malignant cell lines (MCF10A and MCF12A). The gene discussed is PAFAH1B1; the disease is neoplasm.